Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study.
Meca-Lallana JE, Prieto González JM, Caminero Rodríguez AB, Olascoaga Urtaza J, Alonso AM, Durán Ferreras E, Espinosa R, Dotor J, Romera M, Ares Luque A, Pérez Ruiz D, Calles C, Hernández MA, Hervás García M, Mendoza Rodríguez A, Berdei Montero Y, Téllez N, Herrera Varó N, Sotoca J, Presas-Rodríguez S, Querol Gutierrez LA, Hervás Pujol M, Batlle Nadal J, Martín Ozaeta G, Gubieras Lillo L, Martínez Yélamos S, Ramió-Torrentà L, Mallada Frechin J, Belenguer Benavides A, Gascón-Giménez F, Casanova B, Landete Pascual L, Berenguer L, Navarro L, Gómez Gutierrez M, Durán C, Rodríguez Regal A, Álvarez E, García-Estévez DA, López Real AM, Llaneza González MA, Marzo Sola ME, Sánchez-Menoyo JL, Oterino A, Villaverde González R, Castillo-Triviño T, Álvarez de Arcaya A, Llarena C. Meca-Lallana JE, et al. Among authors: mallada frechin j. Neurol Ther. 2023 Dec;12(6):2177-2193. doi: 10.1007/s40120-023-00557-7. Epub 2023 Oct 20. Neurol Ther. 2023. PMID: 37861931 Free PMC article.
Perception of the validity of the Migraine Disability Assessment questionnaire in a population of patients with chronic migraine.
Medrano Martínez V, Francés Pont I, Hernández Rubio L, González Fernández L, Fernández Izquierdo S, Mallada Frechin J. Medrano Martínez V, et al. Among authors: mallada frechin j. Neurologia (Engl Ed). 2021 Nov-Dec;36(9):692-697. doi: 10.1016/j.nrleng.2020.08.004. Epub 2020 Aug 13. Neurologia (Engl Ed). 2021. PMID: 34752347 Free article.
Discontinuation of disease-modifying treatments in multiple sclerosis to plan a pregnancy: A retrospective registry study.
Villaverde-González R, Candeliere-Merlicco A, Alonso-Frías MA, Aparicio Castro E, Carrillo Alcaraz A, Mallada Frechín J, Pérez Sempere Á. Villaverde-González R, et al. Among authors: mallada frechin j. Mult Scler Relat Disord. 2020 Nov;46:102518. doi: 10.1016/j.msard.2020.102518. Epub 2020 Sep 16. Mult Scler Relat Disord. 2020. PMID: 32977075
Episodic migraine and chest pain as the first manifestation of small cell lung carcinoma.
Torregrosa García A, Medrano-Martínez V, Abuomar A, Francés-Pont I, Hernández-Rubio L, Fernández-Izquierdo S, Mallada-Frechin J. Torregrosa García A, et al. Among authors: mallada frechin j. Clin Case Rep. 2020 May 1;8(8):1346-1348. doi: 10.1002/ccr3.2618. eCollection 2020 Aug. Clin Case Rep. 2020. PMID: 32884750 Free PMC article.
Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study.
Barrero F, Mallada-Frechin J, Martínez-Ginés ML, Marzo ME, Meca-Lallana V, Izquierdo G, Ara JR, Oreja-Guevara C, Meca-Lallana J, Forero L, Sánchez-Vera I, Moreno MJ; in representation of the MS NEXT study investigators. Barrero F, et al. Among authors: mallada frechin j. PLoS One. 2020 Apr 2;15(4):e0230846. doi: 10.1371/journal.pone.0230846. eCollection 2020. PLoS One. 2020. PMID: 32240213 Free PMC article.
Perception of the validity of the Migraine Disability Assessment questionnaire in a population of patients with chronic migraine.
Medrano Martínez V, Francés Pont I, Hernández Rubio L, González Fernández L, Fernández Izquierdo S, Mallada Frechin J. Medrano Martínez V, et al. Among authors: mallada frechin j. Neurologia (Engl Ed). 2018 Nov 16:S0213-4853(18)30195-6. doi: 10.1016/j.nrl.2018.09.001. Online ahead of print. Neurologia (Engl Ed). 2018. PMID: 30455123 Free article. English, Spanish.
Reversible Homonymous Inferior Quadrantanopia in a Nonketotic Hyperglycemic Patient.
López-Amorós A, Medrano-Martínez V, Francés-Pont I, Hernández-Rubio L, González-Fernández L, Fernández-Izquierdo S, Mallada-Frechin J. López-Amorós A, et al. Among authors: mallada frechin j. Neuroophthalmology. 2018 Nov 19;44(1):45-48. doi: 10.1080/01658107.2018.1547914. eCollection 2020 Feb. Neuroophthalmology. 2018. PMID: 32076450 Free PMC article.
[Efficacy and safety of fingolimod in routine clinical practice in patients with relapsing-remitting multiple sclerosis in Spain: an intermediate analysis of the MS NEXT study].
Mallada-Frechin J, Meca-Lallana V, Barrero F, Martinez-Gines ML, Marzo-Sola ME, Ricart J, Garcia E, En Representacion de Los Investigadores Del Estudio Ms Next ERLIDEMN. Mallada-Frechin J, et al. Rev Neurol. 2018 Sep 1;67(5):157-167. Rev Neurol. 2018. PMID: 30047118 Free article. Spanish.
Progressive Demyelination in the Presence of Serum Myelin Oligodendrocyte Glycoprotein-IgG: A Case Report.
Gil-Perotin S, Castillo-Villalba J, Carreres-Polo J, Navarré-Gimeno A, Mallada-Frechín J, Pérez-Miralles F, Gascón F, Alcalá-Vicente C, Cubas-Nuñez L, Casanova-Estruch B. Gil-Perotin S, et al. Among authors: mallada frechin j. Front Neurol. 2018 May 15;9:340. doi: 10.3389/fneur.2018.00340. eCollection 2018. Front Neurol. 2018. PMID: 29867746 Free PMC article.
25 results